PL2173337T3 - Fosfaplatyny i ich zastosowanie w leczeniu raków opornych na cisplatynę i karboplatynę - Google Patents
Fosfaplatyny i ich zastosowanie w leczeniu raków opornych na cisplatynę i karboplatynęInfo
- Publication number
- PL2173337T3 PL2173337T3 PL08797320T PL08797320T PL2173337T3 PL 2173337 T3 PL2173337 T3 PL 2173337T3 PL 08797320 T PL08797320 T PL 08797320T PL 08797320 T PL08797320 T PL 08797320T PL 2173337 T3 PL2173337 T3 PL 2173337T3
- Authority
- PL
- Poland
- Prior art keywords
- phosphaplatins
- cisplantin
- carboplatin
- treatment
- cancers resistant
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 190000008236 carboplatin Chemical compound 0.000 title 1
- 229960004562 carboplatin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95412607P | 2007-08-06 | 2007-08-06 | |
| US97392607P | 2007-09-20 | 2007-09-20 | |
| EP08797320.2A EP2173337B1 (en) | 2007-08-06 | 2008-08-06 | Phosphaplatins and their use in the treatment of cancers resistant to cisplantin and carboplatin |
| PCT/US2008/072398 WO2009021082A2 (en) | 2007-08-06 | 2008-08-06 | Phosphaplatins and their use in the treatment of cancers resistant to cisplantin and carboplatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2173337T3 true PL2173337T3 (pl) | 2014-11-28 |
Family
ID=40342030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08797320T PL2173337T3 (pl) | 2007-08-06 | 2008-08-06 | Fosfaplatyny i ich zastosowanie w leczeniu raków opornych na cisplatynę i karboplatynę |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US7700649B2 (pl) |
| EP (2) | EP2173337B1 (pl) |
| JP (2) | JP5385274B2 (pl) |
| CN (1) | CN101801369B (pl) |
| CY (1) | CY1115504T1 (pl) |
| DK (1) | DK2173337T3 (pl) |
| ES (1) | ES2495743T3 (pl) |
| HK (1) | HK1143551A1 (pl) |
| HR (1) | HRP20140808T1 (pl) |
| PL (1) | PL2173337T3 (pl) |
| PT (1) | PT2173337E (pl) |
| SI (1) | SI2173337T1 (pl) |
| WO (2) | WO2009021082A2 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2173337T3 (da) * | 2007-08-06 | 2014-09-15 | Univ Ohio | Phosphaplatiner og deres anvendelse i behandlingen af cancer, der er resistent over for cisplatin og carboplatin |
| CN108299508A (zh) * | 2010-06-04 | 2018-07-20 | 俄亥俄大学 | 磷铂及其在治疗癌症中的用途 |
| US20130236568A1 (en) | 2011-01-12 | 2013-09-12 | Ohio University | Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof |
| BR112014000321B1 (pt) | 2011-07-08 | 2020-11-03 | Dow Global Technologies Llc. | composição de mistura de polietileno, filme soprado, artigo e dispositivo recipiente |
| CN104010508B (zh) * | 2011-10-05 | 2017-03-15 | 理辛德拉·N·博斯 | 用于大规模制备磷铂类抗肿瘤剂的高效方法 |
| JP6027619B2 (ja) | 2011-10-05 | 2016-11-16 | ラシンドラ・エヌ・ボーズ | ホスファプラチン系抗腫瘍剤の大規模調製のための効率的プロセス |
| WO2013059753A1 (en) | 2011-10-20 | 2013-04-25 | Nerium Biotechnology, Inc. | Therapeutic combination for the treatment of cancer |
| SI2855496T1 (sl) * | 2012-05-24 | 2017-04-26 | Phosplatin Therapeutics Llc | Sintezni postopki in postopki čiščenja za fosfaplatinove spojine in njihove uporabe |
| WO2014130776A1 (en) | 2013-02-22 | 2014-08-28 | University Of Houston | Phosphaplatins as neuroprotective agents |
| EP3107534A4 (en) * | 2014-02-19 | 2017-09-06 | The University Of Houston System | Compositions and methods for the treatment of neurodegenerative diseases |
| CN116178456A (zh) | 2014-06-11 | 2023-05-30 | 德克萨斯州大学系统董事会 | 用于克服铂耐受性的德克萨卟啉-pt(iv)缀合物及组合物 |
| WO2017116356A1 (en) | 2015-12-30 | 2017-07-06 | Atilim Universitesi | Dna targeted mono and heterodinuclear complexes |
| KR20190103258A (ko) | 2017-01-06 | 2019-09-04 | 포스플라틴 테라퓨틱스 엘엘씨 | 뼈 또는 혈액 암의 치료를 위한 치료제로서의 포스파플라틴 화합물 |
| AU2018327339B2 (en) | 2017-09-08 | 2023-10-12 | Promontory Therapeutics Inc. | Phosphaplatin compounds as immuno-modulatory agents and therapeutic uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4234500A (en) * | 1979-03-07 | 1980-11-18 | Engelhard Minerals & Chemicals Corporation | Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes |
| US4291027A (en) | 1979-03-07 | 1981-09-22 | Engelhard Minerals & Chemicals Corp. | Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes |
| CA2017739A1 (en) * | 1989-07-18 | 1991-01-18 | Leslie S. Hollis | Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents |
| JP4463274B2 (ja) * | 2003-06-27 | 2010-05-19 | 明 小谷 | ビスホスホネート錯体 |
| EP2177525A1 (en) * | 2007-07-06 | 2010-04-21 | TMRC Co., Ltd. | Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound |
| DK2173337T3 (da) * | 2007-08-06 | 2014-09-15 | Univ Ohio | Phosphaplatiner og deres anvendelse i behandlingen af cancer, der er resistent over for cisplatin og carboplatin |
-
2008
- 2008-08-06 DK DK08797320.2T patent/DK2173337T3/da active
- 2008-08-06 WO PCT/US2008/072398 patent/WO2009021082A2/en active Application Filing
- 2008-08-06 US US12/187,376 patent/US7700649B2/en active Active
- 2008-08-06 WO PCT/US2008/072397 patent/WO2009021081A2/en not_active Application Discontinuation
- 2008-08-06 PL PL08797320T patent/PL2173337T3/pl unknown
- 2008-08-06 ES ES08797320.2T patent/ES2495743T3/es active Active
- 2008-08-06 JP JP2010520294A patent/JP5385274B2/ja active Active
- 2008-08-06 CN CN2008801015774A patent/CN101801369B/zh active Active
- 2008-08-06 PT PT87973202T patent/PT2173337E/pt unknown
- 2008-08-06 EP EP08797320.2A patent/EP2173337B1/en active Active
- 2008-08-06 EP EP13182512.7A patent/EP2668949A1/en not_active Withdrawn
- 2008-08-06 SI SI200831280T patent/SI2173337T1/sl unknown
-
2010
- 2010-03-11 US US12/722,189 patent/US8034964B2/en active Active
- 2010-10-29 HK HK10110187.0A patent/HK1143551A1/xx unknown
-
2011
- 2011-08-30 US US13/221,458 patent/US8445710B2/en active Active
-
2013
- 2013-03-15 US US13/842,885 patent/US8653132B2/en active Active
- 2013-06-07 JP JP2013120309A patent/JP5647300B2/ja active Active
-
2014
- 2014-08-27 HR HRP20140808AT patent/HRP20140808T1/hr unknown
- 2014-08-27 CY CY20141100686T patent/CY1115504T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1115504T1 (el) | 2017-01-04 |
| US20130237503A1 (en) | 2013-09-12 |
| WO2009021081A3 (en) | 2009-05-07 |
| SI2173337T1 (sl) | 2014-10-30 |
| JP5647300B2 (ja) | 2014-12-24 |
| JP5385274B2 (ja) | 2014-01-08 |
| PT2173337E (pt) | 2014-09-03 |
| US20110313182A1 (en) | 2011-12-22 |
| WO2009021081A2 (en) | 2009-02-12 |
| EP2668949A1 (en) | 2013-12-04 |
| DK2173337T3 (da) | 2014-09-15 |
| CN101801369A (zh) | 2010-08-11 |
| US20100233293A1 (en) | 2010-09-16 |
| US20090042838A1 (en) | 2009-02-12 |
| JP2013227218A (ja) | 2013-11-07 |
| ES2495743T3 (es) | 2014-09-17 |
| EP2173337A2 (en) | 2010-04-14 |
| US8034964B2 (en) | 2011-10-11 |
| HK1143551A1 (en) | 2011-01-07 |
| US8445710B2 (en) | 2013-05-21 |
| HRP20140808T1 (hr) | 2014-10-24 |
| US8653132B2 (en) | 2014-02-18 |
| JP2010535803A (ja) | 2010-11-25 |
| US7700649B2 (en) | 2010-04-20 |
| EP2173337A4 (en) | 2010-10-27 |
| WO2009021082A3 (en) | 2009-04-23 |
| WO2009021082A2 (en) | 2009-02-12 |
| EP2173337B1 (en) | 2014-07-30 |
| CN101801369B (zh) | 2012-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2173337T3 (pl) | Fosfaplatyny i ich zastosowanie w leczeniu raków opornych na cisplatynę i karboplatynę | |
| HK1170485A1 (zh) | -噻唑烷- -酮衍生物及其在癌症治療中的用途 | |
| IL234064B (en) | A medical combination including trastuzumab-mcc-dm1 and docetaxel for use in the treatment of cancer expressing erbb2 | |
| ZA201109384B (en) | Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases | |
| PT2601961T (pt) | Composições compreendendo lag-3 e anticorpos terapêuticos e as suas utilizações no tratamento de cancro | |
| IL201887A0 (en) | Honokiol analogs and their use in treating cancers | |
| ZA201201434B (en) | Use of metformin in cancer treatment and prevention | |
| HK1136822A1 (en) | Therapeutic compounds and their use in cancer | |
| PL2483278T3 (pl) | Związki benzoksazepinowe stanowiące inhibitor pi3k i ich zastosowanie w leczeniu nowotworu | |
| EP2237785A4 (en) | TRIARYLMETHANE ANALOGUE AND ITS USE IN CANCER TREATMENT | |
| ZA200907245B (en) | Phthalazinone derivatives and their use as medicament to treat cancer | |
| PT2101731T (pt) | Endoxifeno para utilização no tratamento de cancro | |
| HK1209053A1 (zh) | 地來西坦在慢性疼痛的治療中的用途 | |
| EP2148666A4 (en) | Fulvic and fulvalal analogs and their use in cancer treatment | |
| HUE031337T2 (hu) | Opioidok rezisztens rákos betegek kezelésében történõ alkalmazásra | |
| IL201426A0 (en) | Drug combination and its use in the treatment of muscle loss | |
| GB0704982D0 (en) | Improvements in or relating to photodynamic therapy | |
| ZA201202657B (en) | Use of the sparc microenvironment signature in the treatment of cancer | |
| GB0819103D0 (en) | Raphaine compounds and their use in therapy | |
| GB0722338D0 (en) | Novel use and treatment | |
| HUP1000688A2 (en) | Use of trifluoro-phthalimides in the treatment of cancer |